Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA): Its usefulness as an adjunctive diagnostic tool for melanocytic tumors

Journal of Dermatological Science

Volumn 40, Issue 1, 2005, Pages 51-57

  Takata, Minoru ^a   Suzuki, Takefumi ^a   Ansai, Shinichi ^b   Kimura, Tetsunori ^b   Shirasaki, Fumiaki ^c   Hatta, Naohito ^d   Saida, Toshiaki ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sapporo Institute for Dermatopathology   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Chromosomal aberrations; Diagnosis; Malanoma; Multiplex ligation dependent probe amplification (MLPA); Spitz nevus

Indexed keywords

DNA; PARAFFIN;

ANALYTIC METHOD; ARTICLE; CARCINOGENESIS; CHROMOSOME 9P; CHROMOSOME ARM; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC PROCEDURE; DNA EXTRACTION; FEMALE; GENE EXPRESSION PROFILING; GENE LOCATION; GENETIC PROCEDURES; GENOME; HUMAN; HUMAN TISSUE; JUVENILE MELANOMA; MALE; MELANOCYTIC NEVUS; MELANOCYTOSIS; MELANOMA; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SAMPLING; SKIN TUMOR; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; TUMOR VOLUME;

CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENES, P16; HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; MOLECULAR PROBE TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 25644446211     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2005.06.009     Document Type: Article

References (30)

1. D.J. Ruiter, M.C. van Dijk, and C.M. Ferrier Current diagnostic problems in melanoma pathology Semin Cutan Med Surg 22 2003 33 41
2. E.R. Farmer, R. Gonin, and M.P. Hanna Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists Hum Pathol 27 1996 528 531
3. R. Corona, A. Mele, M. Amini, G. De Rosa, G. Coppola, and P. Piccardi Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions J Clin Oncol 14 1996 1218 1223
4. R.L. Barnhill, Z.B. Argenyi, L. From, L.F. Glass, J.C. Maize, and M.C. Mihm Jr. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome Hum Pathol 30 1999 513 520
5. K.S. McGinnis, S.R. Lessin, D.E. Elder, D.T. Guerry, L. Schuchter, and M. Ming Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic Arch Dermatol 138 2002 617 621
6. K.C. Veenhuizen, P.E. De Wit, W.J. Mooi, E. Scheffer, A.L. Verbeek, and D.J. Ruiter Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party J Pathol 182 1997 266 272
7. T.S. Winokur, J.P. Palazzo, W.C. Johnson, and P.H. Duray Evaluation of DNA ploidy in dysplastic and Spitz nevi by flow cytometry J Cutan Pathol 17 1990 342 347
8. L.X. Li, K.A. Crotty, A.A. Palmer, J.J. Kril, R. Stankovic, and R.A. Scolyer Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation: a zonal comparison, correlation and multivariate analysis Anal Quant Cytol Histol 24 2002 234 243
9. G. Leitinger, L. Cerroni, H.P. Soyer, J. Smolle, and H. Kerl Morphometric diagnosis of melanocytic skin tumors Am J Dermatopathol 12 1990 441 445
10. L. Kanter-Lewensohn, M.A. Hedblad, J. Wejde, and O. Larsson Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas Mod Pathol 10 1997 917 920
11. A. Ribe, and N.S. McNutt S100A6 protein expression is different in Spitz nevi and melanomas Mod Pathol 16 2003 505 511
12. B.C. Bastian, A.B. Olshen, P.E. LeBoit, and D. Pinkel Classifying melanocytic tumors based on DNA copy number changes Am J Pathol 163 2003 1765 1770
13. B.C. Bastian, P.E. LeBoit, and D. Pinkel Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features Am J Pathol 157 2000 967 972
14. B.C. Bastian, U. Wesselmann, D. Pinkel, and P.E. Leboit Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma J Invest Dermatol 113 1999 1065 1069
15. B.C. Bastian Molecular genetics of melanocytic neoplasia: practical applications for diagnosis Pathology 36 2004 458 461
16. M. Takata, K. Maruo, T. Kageshita, S. Ikeda, T. Ono, and F. Shirasaki Two cases of unusual acral melanocytic tumors: illustration of molecular cytogenetics as a diagnostic tool Hum Pathol 34 2003 89 92
17. M.C. van Dijk, P.D. Rombout, S.H. Boots-Sprenger, H. Straatman, M.R. Bernsen, and D.J. Ruiter Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue Diagn Mol Pathol 14 2005 9 16
18. J.P. Schouten, C.J. McElgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens, and G. Pals Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Nucleic Acids Res 30 2002 e57
19. M.J. Worsham, G. Pals, J.P. Schouten, R.M. Van Spaendonk, A. Concus, and T.E. Carey Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma Arch Otolaryngol Head Neck Surg 129 2003 702 708
20. C. Postma, M.A. Hermsen, J. Coffa, J.P. Baak, J.D. Mueller, and E. Mueller Chromosomal instability in flat adenomas and carcinomas of the colon J Pathol 205 2005 514 521
21. M. Mitas, K. Mikhitarian, C. Walters, P.L. Baron, B.M. Elliott, and T.E. Brothers Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel Int J Cancer 93 2001 162 171
22. E. Healy, C.E. Belgaid, M. Takata, A. Vahlquist, I. Rehman, and H. Rigby Allelotypes of primary cutaneous melanoma and benign melanocytic nevi Cancer Res 56 1996 589 593
23. B.C. Bastian, P.E. LeBoit, H. Hamm, E.B. Brocker, and D. Pinkel Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization Cancer Res 58 1998 2170 2175
24. M.C. van Dijk, P.D. Rombout, W.J. Mooi, F.J. van de Molengraft, J.H. van Krieken, and D.J. Ruiter Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours J Pathol 197 2002 170 178
25. N.L. Sieben, N.T. ter Haar, C.J. Cornelisse, G.J. Fleuren, and A.M. Cleton-Jansen PCR artifacts in LOH and MSI analysis of microdissected tumor cells Hum Pathol 31 2000 1414 1419
26. O. Bluteau, P. Legoix, P. Laurent-Puig, and J. Zucman-Rossi PCR-based genotyping can generate artifacts in LOH analyses Biotechniques 27 1999 1100 1102
27. P. Guldberg, P. thor Straten, A. Birck, V. Ahrenkiel, A.F. Kirkin, and J. Zeuthen Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma Cancer Res 57 1997 3660 3663
28. S.F. Goldberg, M.E. Miele, N. Hatta, M. Takata, C. Paquette-Straub, and L.P. Freedman Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP Cancer Res 63 2003 432 440
29. H. Tanami, I. Imoto, A. Hirasawa, Y. Yuki, I. Sonoda, and J. Inoue Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines Oncogene 23 2004 8796 8804
30. B.C. Bastian, M. Kashani-Sabet, H. Hamm, T. Godfrey, D.H. Moore II, and E.B. Brocker Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin Cancer Res 60 2000 1968 1973